Z-2625-2023 Class II Ongoing
FDA device recall Z-2625-2023 was initiated by Remote Diagnostic Technologies Ltd. on Aug 24, 2023 and is designated Class II. Reason for recall: Full screen error message may occur on patient monitors with affected hardware version, either during or after laryngoscopes are unplugged from monitors, informing users a 60-100 second… The recall status is ongoing. Affected quantity: 3,524.
Recall details
- Product Type
- Devices
- Report Date
- Sep 27, 2023
- Initiation Date
- Aug 24, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,524
Product description
Reason for recall
Distribution pattern
US:AZ, AL, CA, CO, DC, DE, FL , GA, HI, IA, ID, IL, IN , KS, KY, MA , MD , ME, MI, MN, MO, MS, MT, NC , ND, NE, NJ, NM , NV, NY, OH, OK, OR, PA, TN, TX, UT, VA , WA, WI, WV, WY. OUS: AE, AT, AU, BE, BN, BO, CA, CH, CZ, DE, DK, ES, FR, GB, HK, IE, IL, IS, IT, KY, LU, MY, NL, NO, OM, PT, RO, SA, SE, SG, SI, TH, YT, ZA
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2625-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026